Visualization analysis of Kawasaki disease research literature based on CiteSpace_West China Medical Journal

Authors：

 CHE Zhongli

Department of Pediatrics, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, P. R. China;

Corresponding author：

CHE Zhongli, Email: chezhongli123@163.com

Keywords：

Kawasaki disease; mucocutaneous lymph node syndrome; visual analysis; CiteSpace

DOI：

10.7507/1002-0179.202006027

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To analysis the research status and hotspot in the field of Kawasaki disease (KD) in recent 10 years. Methods The relevant documents included in the core database of Web of Science from 2010 to 2021 were searched, to analyze the cooperation relationship among authors, countries and institutions by CiteSpace software, analyze the co-occurrence, cluster analysis, dynamic frontier evolution and emergence of keywords, analyze the co citation of cited journals and documents, draw a visual map and analyze. Result A total of 3 041 articles were included, and there were 114 core authors. USA was the core country in the research field of KD, while China occupied a place. University of California, San Diego and Montreal University were the core research institutions. Circulation was the core journal. Keywords formed 7 clusters, and there were a total of 62 emergent words. Conclusions In the past 10 years, the research on KD has shown an upward trend. The research hot spots focus on the diagnosis and treatment, management, pathogenesis, epidemiological research of KD, and the research on Kawasaki-like diseases during the coronavirus disease 2019. Predicting the long-term management of KD, related research on intravenous immunoglobulin resistance and cytokines are the research frontiers in this field.

Citation： CHE Zhongli. Visualization analysis of Kawasaki disease research literature based on CiteSpace. West China Medical Journal, 2022, 37(6): 909-915. doi: 10.7507/1002-0179.202006027 Copy

1.	施惠宣, 陈国兵, 陈先睿. 川崎病合并 G6PD 缺乏症 1 例并文献复习. 临床荟萃, 2020, 35(6): 555-557.
2.	Dimitriades VR, Brown AG, Gedalia A. Kawasaki disease: pathophysiology, clinical manifestations and management. Curr Rheumatol Rep, 2014, 16(6): 423.
3.	石晓青, 李一飞, 华益民, 等. 基于多元统计和社会网络分析我国川崎病诊疗现状的可视化研究. 中华妇幼临床医学杂志 (电子版), 2013, 9(6): 723-729.
4.	Lo MS. A framework for understanding Kawasaki disease pathogenesis. Clin Immunol, 2020, 214: 108385.
5.	Riphagen S, Gomez X, Gonzalez-Martinez C, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet, 2020, 395(10237): 1607-1608.
6.	Chen Chaomei. CiteSpace Ⅱ: detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Technol, 2006, 57(3): 359-377.
7.	贾路, 张云军, 胡英化. 近 10 年包虫病研究的文献计量学分析. 预防医学情报杂志, 2013, 29(12): 1103-1105.
8.	Liang C, Luo A, Zhong Z. Knowledge mapping of medication literacy study: a visualized analysis using CiteSpace. SAGE Open Med, 2018, 6: 2050312118800199.
9.	叶佳美, 胡晓敏, 王丽群, 等. 间充质干细胞治疗脊髓损伤的可视化分析. 中国康复理论与实践, 2020, 26(4): 400-406.
10.	McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation, 2017, 135(17): e927-e999.
11.	Kobayashi T, Saji T, Otani T, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet, 2012, 379(9826): 1613-1620.
12.	Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol, 2012, 22(2): 79-85.
13.	Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet, 2020, 395(10239): 1771-1778.
14.	Whittaker E, Bamford A, Kenny J, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA, 2020, 324(3): 259-269.
15.	Onouchi Y, Gunji T, Burns JC, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet, 2008, 40(1): 35-42.
16.	王志娟, 毕琳, 姜桐桐, 等. 基于 CiteSpace Ⅲ的我国产科护理相关文献的计量学分析. 护理研究, 2018, 32(13): 2066-2070.

1. 施惠宣, 陈国兵, 陈先睿. 川崎病合并 G6PD 缺乏症 1 例并文献复习. 临床荟萃, 2020, 35(6): 555-557.
2. Dimitriades VR, Brown AG, Gedalia A. Kawasaki disease: pathophysiology, clinical manifestations and management. Curr Rheumatol Rep, 2014, 16(6): 423.
3. 石晓青, 李一飞, 华益民, 等. 基于多元统计和社会网络分析我国川崎病诊疗现状的可视化研究. 中华妇幼临床医学杂志 (电子版), 2013, 9(6): 723-729.
4. Lo MS. A framework for understanding Kawasaki disease pathogenesis. Clin Immunol, 2020, 214: 108385.
5. Riphagen S, Gomez X, Gonzalez-Martinez C, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet, 2020, 395(10237): 1607-1608.
6. Chen Chaomei. CiteSpace Ⅱ: detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Technol, 2006, 57(3): 359-377.
7. 贾路, 张云军, 胡英化. 近 10 年包虫病研究的文献计量学分析. 预防医学情报杂志, 2013, 29(12): 1103-1105.
8. Liang C, Luo A, Zhong Z. Knowledge mapping of medication literacy study: a visualized analysis using CiteSpace. SAGE Open Med, 2018, 6: 2050312118800199.
9. 叶佳美, 胡晓敏, 王丽群, 等. 间充质干细胞治疗脊髓损伤的可视化分析. 中国康复理论与实践, 2020, 26(4): 400-406.
10. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation, 2017, 135(17): e927-e999.
11. Kobayashi T, Saji T, Otani T, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet, 2012, 379(9826): 1613-1620.
12. Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol, 2012, 22(2): 79-85.
13. Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet, 2020, 395(10239): 1771-1778.
14. Whittaker E, Bamford A, Kenny J, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA, 2020, 324(3): 259-269.
15. Onouchi Y, Gunji T, Burns JC, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet, 2008, 40(1): 35-42.
16. 王志娟, 毕琳, 姜桐桐, 等. 基于 CiteSpace Ⅲ的我国产科护理相关文献的计量学分析. 护理研究, 2018, 32(13): 2066-2070.

West China Medical Journal

Visualization analysis of Kawasaki disease research literature based on CiteSpace

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content